A2 Corp, which markets milk products with a protein variant claimed to have health benefits, had its shares halted from trading pending a statement.
The Sydney-based company, whose shares have more than doubled in the past 12 months, said last week it is in talks with the NZX about shifting its listing to the main board from the NZAX, a market for smaller companies and start-ups.
The shares traded at 67 cents yesterday, valuing the company at $399 million.
"A move to the NZX main board may provide greater liquidity and increase access to capital," managing director Geoffrey Babidge said last week.
Last month, the company completed a six-month strategic review and has embarked on plans to take control of its New Zealand marketing and accelerate its global expansion.
This article is tagged with the following keywords. Find out more about MyNBR Tags
Most listened to
- Tim Hunter on why Veritas is doing it the hard way
- Matthew Hooton on whether Steven Joyce will be the next national leader
- Rodney Hide on why all city planners should be fired
- Nevil Gibson discusses his latest Editor's Insight on films
- The NBR crew throw around some of the week's top stories
- Rob Hosking breaks down the political and economic week that was
- "A tragedy" - David Farrar on his disappointment with Simon Bridges
- New F&P product pipeline exciting, says Macquarie senior investment adviser Brad Gordon
- Taupo Motorsport Park executive director Tony Walker on the park's rebranding
- NZIER senior economist Christina Leung on why she does not think the OCR will hit 2%
- NBR's Cameron Officer talks about the NBR Car of the Year 2015
- John Barnett on Brewer: ‘Boy, has he got a bit to learn’